Robert R. Bower

653 total citations
16 papers, 535 citations indexed

About

Robert R. Bower is a scholar working on Epidemiology, Pharmacology and Molecular Medicine. According to data from OpenAlex, Robert R. Bower has authored 16 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Pharmacology and 5 papers in Molecular Medicine. Recurrent topics in Robert R. Bower's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Pneumonia and Respiratory Infections (3 papers). Robert R. Bower is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Pneumonia and Respiratory Infections (3 papers). Robert R. Bower collaborates with scholars based in United States and United Kingdom. Robert R. Bower's co-authors include N. L. Shipkowitz, Prabhavathi Fernandes, N Ramer, Dwight J. Hardy, R. N. Swanson, C W Hanson, D. T. W. CHU, J. B. Schleicher, William R. Roderick and Robert T. Bailer and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Robert R. Bower

15 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert R. Bower United States 11 217 217 162 149 102 16 535
P. Acred United Kingdom 14 311 1.4× 160 0.7× 136 0.8× 236 1.6× 145 1.4× 30 675
R Pallanza Italy 15 194 0.9× 149 0.7× 198 1.2× 91 0.6× 214 2.1× 28 614
S L Haskell United States 8 221 1.0× 228 1.1× 143 0.9× 168 1.1× 128 1.3× 8 569
K Roholt Denmark 11 273 1.3× 115 0.5× 167 1.0× 88 0.6× 130 1.3× 22 716
Valerie Berry United States 14 161 0.7× 153 0.7× 152 0.9× 128 0.9× 85 0.8× 20 708
Dena M. Hensey United States 9 233 1.1× 239 1.1× 140 0.9× 141 0.9× 126 1.2× 9 574
C W Hanson United States 14 257 1.2× 316 1.5× 189 1.2× 205 1.4× 265 2.6× 20 708
E. Schrinner Germany 14 361 1.7× 150 0.7× 115 0.7× 275 1.8× 127 1.2× 36 576
L. Tybring Denmark 12 392 1.8× 167 0.8× 264 1.6× 238 1.6× 174 1.7× 24 917
MARGARET R. ANDERSON United States 5 189 0.9× 206 0.9× 105 0.6× 168 1.1× 115 1.1× 6 537

Countries citing papers authored by Robert R. Bower

Since Specialization
Citations

This map shows the geographic impact of Robert R. Bower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert R. Bower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert R. Bower more than expected).

Fields of papers citing papers by Robert R. Bower

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert R. Bower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert R. Bower. The network helps show where Robert R. Bower may publish in the future.

Co-authorship network of co-authors of Robert R. Bower

This figure shows the co-authorship network connecting the top 25 collaborators of Robert R. Bower. A scholar is included among the top collaborators of Robert R. Bower based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert R. Bower. Robert R. Bower is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fernandes, Prabhavathi, D. T. W. CHU, R. N. Swanson, et al.. (1988). A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy. 32(1). 27–32. 26 indexed citations
2.
Shipkowitz, N. L., et al.. (1987). Murine Models for Studying the Pathogenesis and Treatment of Pyelonephritis. Advances in experimental medicine and biology. 224. 35–51. 4 indexed citations
3.
Hardy, Dwight J., R. N. Swanson, Dena M. Hensey, et al.. (1987). Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones. Antimicrobial Agents and Chemotherapy. 31(11). 1768–1774. 96 indexed citations
4.
Fernandes, Prabhavathi, Robert T. Bailer, R. N. Swanson, et al.. (1986). In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrobial Agents and Chemotherapy. 30(6). 865–873. 126 indexed citations
5.
Fernandes, Prabhavathi, et al.. (1986). In-vitro and in-vivo potency of five new fluoroquinolones against anaerobic bacteria. Journal of Antimicrobial Chemotherapy. 18(6). 693–701. 38 indexed citations
6.
Fernandes, Prabhavathi, et al.. (1986). In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. Antimicrobial Agents and Chemotherapy. 29(2). 201–208. 29 indexed citations
7.
Fernandes, Prabhavathi, et al.. (1984). Spenolimycin, a new spectinomycin-type antibiotic. III. Biological properties.. The Journal of Antibiotics. 37(12). 1525–1527. 4 indexed citations
8.
Stamm, John M., et al.. (1981). Antimicrobial Activity of Cefmenoxime (SCE-1365). Antimicrobial Agents and Chemotherapy. 19(3). 454–460. 27 indexed citations
9.
Herrin, Thomas, et al.. (1977). Synthesis and anti-herpes simplex activity of analogs of phosphonoacetic acid. Journal of Medicinal Chemistry. 20(5). 660–663. 29 indexed citations
10.
Herrin, Thomas, et al.. (1977). ChemInform Abstract: SYNTHESIS AND ANTI‐HERPES SIMPLEX ACTIVITY OF ANALOGS OF PHOSPHONOACETIC ACID. Chemischer Informationsdienst. 8(39). 5 indexed citations
11.
Shipkowitz, N. L., Robert R. Bower, Carl W. Nordeen, et al.. (1973). Suppression of Herpes Simplex Virus Infection by Phosphonoacetic Acid. Applied Microbiology. 26(3). 264–267. 93 indexed citations
12.
Shipkowitz, N. L., et al.. (1972). Antiviral Activity of a bis-Benzimidazole Against Experimental Rhinovirus Infections in Chimpanzees. Applied Microbiology. 23(1). 117–122. 19 indexed citations
13.
Shipkowitz, N. L., et al.. (1972). Antiviral Activity of a bis-Benzimidazole Against Experimental Rhinovirus Infections in Chimpanzees1. Applied Microbiology. 23(1). 117–122. 14 indexed citations
14.
Martin, Yvonne C., Peter H. Jones, Thomas J. Perun, et al.. (1972). Chemical modification of erythromycin antibiotics. 4. Structure-activity relations of erythromycin esters. Journal of Medicinal Chemistry. 15(6). 635–638. 18 indexed citations
15.
Bower, Robert R., et al.. (1958). The Effect of Erythromycin on Experimental Infectious Sinusitis of Turkeys. Avian Diseases. 2(3). 290–290. 3 indexed citations
16.
Bower, Robert R., et al.. (1955). A microbiological comparison of erythromycin and erythromycin B.. PubMed. 5(4). 212–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026